<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Lupus</journal-id>
<journal-title>Frontiers in Lupus</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Lupus</abbrev-journal-title>
<issn pub-type="epub">2813-6934</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/flupu.2024.1432884</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Lupus</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Microfibrillar-associated protein 4 interaction with inflammation and clinical characteristics in neuropsychiatric systemic lupus erythematosus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wegener</surname><given-names>Maria Alexandra Bandehkhoda</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author"><name><surname>M&#x00F6;ller</surname><given-names>S&#x00F6;ren</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Olesen</surname><given-names>Mads Nikolaj</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Madsen</surname><given-names>Jonna Skov</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Sorensen</surname><given-names>Grith Lykke</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Voss</surname><given-names>Anne</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<xref ref-type="aff" rid="aff10"><sup>10</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Asgari</surname><given-names>Nasrin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/279207/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Department of Neurology, Slagelse Hospital</institution>, <addr-line>Slagelse</addr-line>, <country>Denmark</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Institute of Regional Health Research, University of Southern Denmark</institution>, <addr-line>Odense</addr-line>, <country>Denmark</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Open Patient Data Explorative Network, Odense University Hospital &#x0026; Research Unit OPEN</institution>, <addr-line>Odense</addr-line>, <country>Denmark</country></aff>
<aff id="aff4"><label><sup>4</sup></label><institution>The Department of Clinical Research, University of Southern Denmark</institution>, <addr-line>Odense</addr-line>, <country>Denmark</country></aff>
<aff id="aff5"><label><sup>5</sup></label><institution>Institute of Molecular Medicine, University of Southern Denmark</institution>, <addr-line>Odense</addr-line>, <country>Denmark</country></aff>
<aff id="aff6"><label><sup>6</sup></label><institution>The Department of Clinical Immunology, Odense University Hospital</institution>, <addr-line>Odense</addr-line>, <country>Denmark</country></aff>
<aff id="aff7"><label><sup>7</sup></label><institution>Department of Clinical Biochemistry and Immunology, Lillebaelt Hospital</institution>, <addr-line>Vejle</addr-line>, <country>Denmark</country></aff>
<aff id="aff8"><label><sup>8</sup></label><institution>Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark</institution>, <addr-line>Odense</addr-line>, <country>Denmark</country></aff>
<aff id="aff9"><label><sup>9</sup></label><institution>Department of Rheumatology, Odense University Hospital</institution>, <addr-line>Odense</addr-line>, <country>Denmark</country></aff>
<aff id="aff10"><label><sup>10</sup></label><institution>Research Unit of Rheumatology, University of Southern Denmark</institution>, <addr-line>Odense</addr-line>, <country>Denmark</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited and Reviewed by:</bold> Lu&#x00ED;s Pedro Sousa In&#x00EA;s, Coimbra Hospital and University Center, Portugal</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Nasrin Asgari <email>nasgari@health.sdu.dk</email></corresp>
<fn fn-type="present-address" id="an1"><label><sup>&#x2020;</sup></label><p><bold>Present Addresses:</bold> Mads Nikolaj Olesen,Lundbeck A/S, Copenhagen, Denmark</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>04</day><month>06</month><year>2024</year></pub-date>
<pub-date pub-type="collection"><year>2024</year></pub-date>
<volume>2</volume><elocation-id>1432884</elocation-id>
<history>
<date date-type="received"><day>14</day><month>05</month><year>2024</year></date>
<date date-type="accepted"><day>27</day><month>05</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2024 Wegener, M&#x00F6;ller, Olesen, Madsen, Sorensen, Voss and Asgari.</copyright-statement>
<copyright-year>2024</copyright-year><copyright-holder>Wegener, M&#x00F6;ller, Olesen, Madsen, Sorensen, Voss and Asgari</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<kwd-group>
<kwd>systemic lupus erythematosus</kwd>
<kwd>neuropsychiatric SLE</kwd>
<kwd>inflammation</kwd>
<kwd>microfibrillar-associated protein 4</kwd>
<kwd>accumulated disease damage</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="0"/><page-count count="0"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Clinical Research and Treatment in Lupus</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Lupus" journal-id-type="nlm-ta" xlink:href="10.3389/flupu.2024.1386256" ext-link-type="doi">A Corrigendum on <article-title>Microfibrillar-associated protein 4 interaction with inflammation and clinical characteristics in neuropsychiatric systemic lupus erythematosus</article-title> Wegener MAB, M&#x00F6;ller S&#x00F6;ren, Olesen MN, Madsen JS, Sorensen GL, Voss A and Asgari N (2024). Front. Lupus 2:1386256. doi: <object-id>10.3389/flupu.2024.1386256</object-id></related-article>
<p>In the published article, there was an error. &#x201C;Data not shown&#x201D; should have been deleted. A correction has been made to <bold>3 Results</bold>, <italic>3.5 Markers of BBB disruption</italic>. This sentence previously stated:</p>
<p>&#x201C;Additionally, MMP-2 was significantly elevated in NPSLE patients with CNS manifestations compared to PNS manifestations (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.010, data not shown).&#x201D;</p>
<p>The corrected sentence appears below:</p>
<p>&#x201C;Additionally, MMP-2 was significantly elevated in NPSLE patients with CNS manifestations compared to PNS manifestations (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.010).&#x201D;</p>
<p>In the published article, there was an error. The below sentences in the Discussion should have been deleted. A correction has been made to the <bold>4 Discussion</bold>. The below sentences have been removed:</p>
<p>&#x201C;Interestingly, MFAP4 was associated with SLICC (accumulated disease damage) in the total SLE cohort suggesting that MFAP4 may reflect inflammation. Interestingly, MFAP4 was associated with SLICC in the total SLE cohort suggesting that MFAP4 may reflect inflammation.&#x201D;</p>
<p>In the published article, there was an error in the punctuation of the of caption Figure 4. The corrected legend appears below.</p>
<p>Figure 4. Correlation of MFAP4 with MMP-7 and VEGF in NPSLE subgroup and non-NPSLE subgroup. A significant association was found between MMP-7 and MFAP4 within NPSLE patients (<bold>A</bold>). Likewise, a significant association was found between VEGF and MFAP4 within NPSLE patients (<bold>C</bold>). No association was found between MMP-7 and MFAP4 (<bold>B</bold>) nor between VEGF and MFAP4 (<bold>D</bold>) in the non-NPSLE subgroup. Grey zone, confidence band. MFAP4, microfibrillar-associated protein 4; MMP-7, matrix metalloproteinase 7; VEGF, vascular endothelial growth factor; SLE, systemic lupus erythematosus; NPSLE, neuropsychiatric systemic lupus erythematosus.</p>
<p>The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec id="s1" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>